Sang Kim Ph.D.

Assistant Professor
(508) 849-3351


Ph.D. in Molecular Biology Program, Biophysics and Genetics Department, University of Colorado School of Medicine, Field: Cell cycle regulation in Xenopus

M.S. in Microbiology, California State University-Los Angeles, Field: Molecular virology of Sendai virus

B.S. in Biology, Korea University

Professional Research Experience:

Research Scientist/team leader/supervisor, Oncology research and Therapeutic Innovation Group (2005-2013), Amgen, Inc.

Post-doctoral fellow with Dr. Daniel A. Haber (1999-2005), Massachusetts General Hospital Cancer Center, Harvard Medical School


Dr. Kim came to Anna Maria College with a background in the fields of cell cycle, epigenetics, and cancer biology with expertise in molecular, cellular, and biochemical biology. Since Dr. always wanted to work with young students, he started to teach from 2013.

Prior to joining Anna Maria College, Dr. Kim taught various Biology subjects in several colleges.

Courses Taught at Anna Maria:

Introduction to Chemistry I Lab
Human Anatomy and Physiology I

Research Interests:

Dr. Kim is interested in cancer biology with special expertise in senescence and epigenetic regulation. Also interested in the in vitro biochemical- and cell-based assay development and the translational research through various molecular biology and cell biology techniques.


Kim SH, Mohapatra, G, and Haber, DA. In Vitro Phosphorylation of BRCA2 by the checkpoint kinase CHEK2. Br. J. Cancer. 2008, 99(8):1302-1306.

Bell, D*, Kim,SH*, Godwin, AK, Schiripo, TA, Harris, PL, Haserlat, SM, Wahrer, DC, Haiman, CA, Daly, MB, Niendorf, KB, Smith, MR, Sgroi, DC, Garber, JE, Olopade OI, Le Marchand, L, Henderson, BE, Altshuler, D, Haber,DA, and Freedman, ML. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int. J. Cancer. 2007, 121(12):2661-2667. (*Denotes equal contribution).

Eunice L. Kwak, Sang Kim, Jianmin Zhang, Robert D. Cardiff, Emmett V. Schmidt, and Daniel A. Haber. Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant. Cancer Research. 2006, 66(4):1923-1928.

Zhang J, Willers H, Feng Z, Ghosh J, Kim SH, Weaver D, Chung J, Powell S, and Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Molecular & Cellular Biology. 2004, 24(2):708-718.

Lee SB*, Kim SH*, Bell D*, Wahrer D, Schiripo T, Jorczak M, Sgroi D, Garber J, Li FP, Nichols K, Varley JM, Godwin AK, Shannon KE, Harlow E, and Haber DA. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. (*Denotes equal contribution). Cancer Research. 2001, 61:8062-8067.

Kim SH, Li C, and Maller, JL. A Maternal form of the phosphatase Cdc25A regulates early embryonic cell cycles in Xenopus laevis. Developmental Biology. 1999; 212:381-391.

Schwab MS, Kim SH, Terada N, Edfjall C, Kozma SC, Thomas G, Maller JL. p70 (S6K) controls selective mRNA translation during oocyte maturation and early embryogenesis in Xenopus laevis. Molecular & Cellular Biology. 1999;19(4):2485-2494.